TGA Advise no Change to AstraZeneca Rollout in Australia

Australia’s medical regulator has recommended no changes to the vaccine rollout despite blood clotting in a recipient of the AstraZeneca jab.

Several urgent meetings have been held today after the 44-year-old was admitted to Melbourne’s Box Hill Hospital with abdominal pain.

Acting Chief Medical Officer Professor Michael Kidd said, “at this time the risk of serious disease and death from COVID-19 if we experience a severe outbreak especially among older Australians is far greater than the very small potential risk of a very rare clotting disorder”.

People who experience unusual headaches 4-20 days after vaccination are being told to seek medical advice as soon as possible.

The TGA is working with European regulators as investigations continue and further advice is expected in the coming days.

By Joe Cusmano